ImmPACT Bio

Modulari-T Biosciences

This company develops modular immune receptors and delivery vehicles to create cell and gene therapies for patients with cancer and autoimmune diseases.

T-Cypher Bio

The company develops T-cell receptor therapeutics and immune engagers for patients with cancer and autoimmune diseases.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

Modulari-T Bioscience

This company develops modular immune receptors and delivery vehicles for cell and gene therapies targeting oncology, autoimmunity and regenerative medicine patients.

Cabaletta Bio

This clinical-stage biotechnology company develops engineered T cell therapies for patients with various autoimmune diseases.

ArsenalBio

The company develops programmable T cell therapies for patients with solid tumours and autoimmune diseases.

Umoja Biopharma

This biotechnology company develops in vivo cell therapies to treat oncology and autoimmunity patients by generating chimeric antigen receptor T cells inside the body.

Boulevard Bio

This clinical-stage biotechnology company develops multi-specific antibody therapies for patients suffering from B cell-driven autoimmune diseases.